Table 2.

Results of hyperinsulinemic euglycemic clamp, IVGTT, and IVIRT ($\overline{x}\pm s$).

Group	n	GIR  (mg·kg−1·min−1)	AUCG0–60  (mmol·L−1·min−1)	AUCI0–10  (mIU·L−1·min−1)	AUCI10–60  (mIU·L−1·min−1)	AUCI0–60  (mIU·L−1·min−1)
NC	5	7.80 ± 0.51	57.12 ± 5.38	277.29 ± 5.46	94.57 ± 2.35	371.85 ± 5.97
HF	5	5.32 ± 0.90*	73.63 ± 6.69*	264.46 ± 3.51*	159.67 ± 7.98*	424.13 ± 9.20*
HF+S	5	ND	180.79 ± 7.31∗#	122.84 ± 11.84∗#	94.65 ± 24.67#	217.49 ± 35.67∗#
HF+T+S	5	ND	122.68 ±18.44∗#∇	198.13 ± 13.12∗#∇	124.88 ± 7.80∗#★	326.01 ± 19.68∗#∇

NC: normal control group; HF: high-fat diet group; HF+S: high-fat diet plus STZ intraperitoneal injection group; HF+T+S: high-fat diet plus telmisartan intervention and STZ intraperitoneal injection group.

GIR: glucose infusion rate; AUCG: area under the curve of glucose; AUCI: area under the curve of insulin.

^● P < 0.05; *P < 0.01 as compared with NC group; ^▲ P < 0.05, ^#<0.01 as compared with HF group; ^★<0.05, ^∇<0.01 as compared with HF+S group.